Relevamiento epidemiológico nacional de recursos neurológicos: presencia de centros de tratamiento del accidente cerebro vascular con trombolíticos en Argentina

WHO Global Infobase. Wordl Health Organization [consultado 9 Mayo 2015]. Disponible en: https://apps.who.int/infobase/Mortality.aspx Feigin, 2014, Global and regional burden of stroke during 1990-2010: Findings from the Global Burden of Disease Study 2010, on behalf of the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group, Lancet, 383, 245, 10.1016/S0140-6736(13)61953-4 Mathers, 2006, Projections of global mortality and burden of disease from 2002 to 2030, PLoS Med., 3, e442, 10.1371/journal.pmed.0030442 1996, European strategies for early intervention in stroke. A report of an hoc consensus group meeting, Cerebrovasc Dis, 6, 315, 10.1159/000108045 Adams, 2007, Stroke., 38, 1655, 10.1161/STROKEAHA.107.181486 Mar, 2005, Cost-effectiveness analysis of thrombolytic treatment for stroke, Cerebrovasc Dis, 20, 193, 10.1159/000087204 Yip, 2007, Estimated cost savings of increased use of intravenous tissue plasminogen activator for acute ischemic stroke in Canada, Stroke, 38, 1952, 10.1161/STROKEAHA.106.479477 Official Publication of Joint Commission Requirements. Requirements for Acute Stroke-Ready. Hospital Advanced Certification. En línea [consultado 2 Abril 2015]. Sitio de Joint Commisision. Disponible en: http://www.jointcommission.org/assets/1/18/PREPUB_ASRH_20150202_Run20150113.pdf Clark ML1, 2015, Advances in the stroke system of care, Curr Treat Options Cardiovasc Med., 17, 355, 10.1007/s11936-014-0355-9 Sposato, 2008, Quality of ischemic stroke care in emerging countries: The Argentinian National Stroke Registry (ReNACer), Stroke., 39, 3036, 10.1161/STROKEAHA.108.521062